Get started
Author

Sarah Buchs

Observed names: Buchs, Sarah, S Buchs, S. Buchs
OpenAlex ID: A5086481579
The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents
2018 · Michael S. Blaiss, Eva Hammerby, et al. · Annals of Allergy Asthma & Immunology · 228
Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
2021 · Benedikt Fritzsching, Marco Contoli, et al. · The Lancet Regional Health - Europe · 154
PDF
Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study
2023 · Marco Contoli, Celeste Porsbjerg, et al. · Journal of Allergy and Clinical Immunology · 33
PDF
Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis
2017 · Nicolaas C. Schaper, Annie Nikolajsen, et al. · Diabetes Therapy · 29
PDF
Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population
2017 · Maral DerSarkissian, Rachel H. Bhak, et al. · Current Medical Research and Opinion · 22
The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data
2021 · Andrew Briggs, Shuaib Nasser, et al. · Journal of Patient-Reported Outcomes · 18
PDF
Real-world evidence: Methods for assessing long-term health and effectiveness of allergy immunotherapy
2021 · Benedikt Fritzsching, Marco Contoli, et al. · Journal of Allergy and Clinical Immunology · 15
PDF
Projected long‐term outcomes in patients with type 1 diabetes treated with fast‐acting insulin aspart vs conventional insulin aspart in the UK setting
2017 · David Russell‐Jones, Simon R. Heller, et al. · Diabetes Obesity and Metabolism · 10
PDF
High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study
2023 · Benedikt Fritszching, Celeste Porsbjerg, et al. · Frontiers in Pediatrics · 7
PDF
Long-term health care resource and cost savings with allergy immunotherapy: REACT study results
2023 · Benedikt Fritzsching, Celeste Porsbjerg, et al. · Journal of Allergy and Clinical Immunology Global · 6
PDF
Budget impact of treating commercially insured type 1 and type 2 diabetes patients in the United States with insulin degludec compared to insulin glargine
2016 · James Weatherall, Lisa Bloudek, et al. · Current Medical Research and Opinion · 5
A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial
2019 · Katherine Dick, Andrew Briggs, et al. · Journal of Medical Economics · 4
PDF
Cost-effectiveness of the SQ HDM SLIT-tablet for the treatment of allergic asthma in three Eastern European Countries
2018 · W. Green, J. McMaster, et al. · European Annals of Allergy and Clinical Immunology · 3
PDF
A Review of The Quality of Life and Educational Burden of Allergic Rhinitis on Adolescents
2017 · S Robinson, S Buchs, et al. · Value in Health · 3
A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes
2018 · J. Jendle, A. Sandberg, et al. · Journal of Patient-Reported Outcomes · 2
PDF
Improvements in Health-Related Quality of Life Associated with Increased Control of Postprandial Glucose Levels in Diabetes
2016 · A Sandberg, S Buchs, et al. · Value in Health · 2
Timing of Insulin Injections Predicts Type 2 Diabetes Control and Adherence in a Multinational Sample
2016 · A Nikolajsen, N Schaper, et al. · Value in Health · 2
Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma – Authors´ reply
2022 · Benedikt Fritzsching, Marco Contoli, et al. · The Lancet Regional Health - Europe · 1
PDF
The long-term effectiveness of allergy immunotherapy in subjects with asthma is associated with a lower prevalence of sleep disturbances. Results from the REACT-study
2022 · M Contoli, B Fritzsching, et al. · European Respiratory Journal
Allergy immunotherapy is associated with a reduced risk of asthma severity progression and lower airway infections. Results from the REACT-study
2022 · C Porsbjerg, B Fritzsching, et al. · European Respiratory Journal
Efficacité de l’immunothérapie allergénique (ITA) en conditions de vie réelle : résultats de l’étude REACT
2022 · S. Sedghi, S. Amet, et al. · Revue française d'allergologie
Prs23 Developing a Mapping Function to the Sq Tree Sublingual Immunotherapy (slit-tablet) Trial From a Sq Grass Slit-tablet Trial
2019 · A. Briggs, T.S. Grand, et al. · Value in Health
PDF
Prs52 - Cost-minimization Analysis of Sq® Hdm Slit-tablet in Patients With House Dust Mite Allergic Rhinitis With or Without Allergic Asthma in Poland
2018 · G. Obrzut, J. Augustynska, et al. · Value in Health
Prs53 - Cost-utility Analysis of Sq® Hdm Slit-tablet in Patients With House Dust Mite Allergic Rhinitis With or Without Allergic Asthma in Poland
2018 · G. Obrzut, J. Augustynska, et al. · Value in Health
Treatment with SQ-HDM SLIT-tablet Improves Quality of Life in House Dust Mite Induced Allergic Rhinitis
2018 · Eva Hammerby, Sarah Buchs, et al. · Journal of Allergy and Clinical Immunology
PDF
Works count: 33
Citation count: 544
H-index: 8
I10-index: 8
Year
Topic
Type